Search for Clinical Trial Results
Hypereosinophilic Syndrome - 25 Studies Found
Status | Study |
Available |
Study Name: This Record Contains Information About the Mepolizumab Compassionate Use Product Activities: 104317: An Open-Label Compassionate Use and Long-Term Access Study of Mepolizumab in HES 201956: A Long-term Access Programme for Subjects With Severe Asthma Condition: Hypereosinophilic Syndrome Date: 2005-10-25 Interventions: Drug: Mepolizumab open label investigational product |
Completed |
Study Name: Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes Condition:
Date: 2008-11-06 Interventions: Drug: Imatinib Patients received oral imatinib 100 mg/d; in case of unsatisfactory response (less than c |
Completed |
Study Name: Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias Condition:
|
Recruiting |
Study Name: Eosinophilia Diagnosis Condition: Hypereosinophilic Syndrome Date: 2015-10-19 Interventions: Other: Scheduled exams and diagnosis Scheduled exams and diagnosis circuit as imposed by the algorithm |
Recruiting |
Study Name: Steroid Treatment for Hypereosinophilic Syndrome Condition: Hypereosinophilia Date: 2012-02-01 Interventions: Drug: Corticosteroids |
Completed |
Study Name: 2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES) Condition: Leukemia Date: 2007-06-05 Interventions:
|
Completed |
Study Name: Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome Condition:
Date: 2005-12-15 Interventions: Drug: Mepolizumab 10mg/kg (max 750 ml) once a month for 3 months |
Completed |
Study Name: Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate Condition:
|
Completed |
Study Name: Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) Condition:
|
Completed |
Study Name: Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes Condition:
Interventions: Drug: imatinib mesylate Other Name: STI571 |